İmipraminin Mcf-7 Hücre Hattında Eag1 Potasyum Kanalları Üzerine Sitotoksik ve Elektrofizyolojik Etkileri
Öz
Anahtar Kelimeler
Supporting Institution
Project Number
Thanks
References
- Asher V., Sowter H., Shaw R., Bali A., Kahn R. Eag and HERG potassium channels as novel therapeutic targets in cancer. World Journal of Surgical Oncology 2010; 8(113): 1-9.
- Asher V., Warren A., Shaw R., Sowter H., Bali A., Khan, R. The role of Eag and ERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line. Cancer Cell International 2011; 11(6): 1-7.
- Blackiston D., McLaughlin K., Levin, M. Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle. Cell Cycle 2009; 8(21): 3527-3536.
- Borowıec A., Hague F., Harır N., Gue´Nın S., Guerıneau F., Gouılleux F., Ouadıd-Ahıdouch H. IGF-1 activates hEAG KR channels through an akt-dependent signaling pathway in breast cancer cells: role in cell proliferation. Journal of Cellular Physiology 2007; 212(3): 690-701.
- Catterall, W., Chandy K., Gutman G. Introduction to the IUPHAR compendium of voltage-gated ion channels. Pharmacological Reviews 2005; 57(4): 385-385.
- García-Ferreiro R., Kerschensteiner D., Major F., Monje F., Stühmer W., Pardo L. Mechanism of block of hEag1 K+ channels by imipramine and astemizole. Journal of General Physiology 2004; 124(4): 301–317.
Details
Primary Language
Turkish
Subjects
Structural Biology
Journal Section
Research Article
Authors
Barış Uçar
*
Türkiye
Ali Aşkın
0000-0002-6862-8430
Türkiye
Fatma Söğüt
0000-0002-1108-8947
Türkiye
Ülkü Çömelekoğlu
0000-0001-8060-6333
Türkiye
Publication Date
January 22, 2024
Submission Date
May 24, 2023
Acceptance Date
September 18, 2023
Published in Issue
Year 2024 Volume: 7 Number: 1